{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-11-16T04:49:37.426467+00:00","published_at":"2026-11-16T04:49:37.426467+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:7:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:andrew-s-plump","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Andrew S. Plump","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:5ba72a5428d5253813178005d729953b373ae659576c4688544dd96896f6f5fe"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:8:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:christophe-weber","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Christophe Weber","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:7bcafb2a13b7a4f4d225d6f990e62aea997765d74e9d316284126511b4eb8d3c"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:9:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:gabriele-ricci","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Gabriele Ricci","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:032ad08cfaf6677ae6bbdec6d09999af087a7232b2103714ef0fbdd67532e0cf"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:10:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:iwaaki-taniguchi","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Iwaaki Taniguchi","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:4d75d88881aa3452d15e42ac5f5e70129a81b4a0cedeadd46721eaafebb5ca8f"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:11:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:milano-furuta","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Milano Furuta","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:0075f8b9affede8845d2b8d817feda25ab8af963875129c9c4b0b418dab40a54"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:12:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:mwana-lugogo","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Mwana Lugogo","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:4a3ab2ce2264c27e9dd58ed26840129bfb82645016e03b406b7c2d24961bea67"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:13:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","relationship_type":"executive_of","from_id":"alpha:person:norimasa-takeda","to_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","from_label":"Norimasa Takeda","to_label":"TAKEDA PHARMACEUTICAL CO LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:5783bae66030e6c612df33383109164a6f2f88cb31effa784a9aa555290e6b5c"]}]},"claims":[{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:7","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:andrew-s-plump","object_label":"Andrew S. Plump","object_source_name_forms":[],"value":"Andrew S. Plump: President of Research & Development and Representative Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:andrew-s-plump","name":"Andrew S. Plump"},"title":"President of Research & Development and Representative Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:5ba72a5428d5253813178005d729953b373ae659576c4688544dd96896f6f5fe","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:10.085378+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:8","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christophe-weber","object_label":"Christophe Weber","object_source_name_forms":[],"value":"Christophe Weber: President, CEO & Representative Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christophe-weber","name":"Christophe Weber"},"title":"President, CEO & Representative Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:7bcafb2a13b7a4f4d225d6f990e62aea997765d74e9d316284126511b4eb8d3c","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:11.253627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:9","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:gabriele-ricci","object_label":"Gabriele Ricci","object_source_name_forms":[],"value":"Gabriele Ricci: Chief Data & Technology Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:gabriele-ricci","name":"Gabriele Ricci"},"title":"Chief Data & Technology Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:032ad08cfaf6677ae6bbdec6d09999af087a7232b2103714ef0fbdd67532e0cf","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:11.81913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:10","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:iwaaki-taniguchi","object_label":"Iwaaki Taniguchi","object_source_name_forms":[],"value":"Iwaaki Taniguchi: Senior Vice President of Corporate Finance & Controlling Department","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:iwaaki-taniguchi","name":"Iwaaki Taniguchi"},"title":"Senior Vice President of Corporate Finance & Controlling Department","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:4d75d88881aa3452d15e42ac5f5e70129a81b4a0cedeadd46721eaafebb5ca8f","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:12.244009+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:11","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:milano-furuta","object_label":"Milano Furuta","object_source_name_forms":[],"value":"Milano Furuta: CFO & Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:milano-furuta","name":"Milano Furuta"},"title":"CFO & Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:0075f8b9affede8845d2b8d817feda25ab8af963875129c9c4b0b418dab40a54","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:12.63363+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:12","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mwana-lugogo","object_label":"Mwana Lugogo","object_source_name_forms":[],"value":"Mwana Lugogo: Chief Ethics & Compliance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mwana-lugogo","name":"Mwana Lugogo"},"title":"Chief Ethics & Compliance Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:4a3ab2ce2264c27e9dd58ed26840129bfb82645016e03b406b7c2d24961bea67","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:13.57874+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:13","subject_id":"alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:norimasa-takeda","object_label":"Norimasa Takeda","object_source_name_forms":[],"value":"Norimasa Takeda: Chief Accounting Officer & Corporate Controller","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:norimasa-takeda","name":"Norimasa Takeda"},"title":"Chief Accounting Officer & Corporate Controller","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:49:37.426467+00:00","sources":[{"id":"alpha:projection-evidence:document:5783bae66030e6c612df33383109164a6f2f88cb31effa784a9aa555290e6b5c","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:13.968512+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:5ba72a5428d5253813178005d729953b373ae659576c4688544dd96896f6f5fe","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:10.085378+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7bcafb2a13b7a4f4d225d6f990e62aea997765d74e9d316284126511b4eb8d3c","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:11.253627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:032ad08cfaf6677ae6bbdec6d09999af087a7232b2103714ef0fbdd67532e0cf","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:11.81913+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4d75d88881aa3452d15e42ac5f5e70129a81b4a0cedeadd46721eaafebb5ca8f","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:12.244009+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0075f8b9affede8845d2b8d817feda25ab8af963875129c9c4b0b418dab40a54","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:12.63363+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4a3ab2ce2264c27e9dd58ed26840129bfb82645016e03b406b7c2d24961bea67","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:13.57874+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5783bae66030e6c612df33383109164a6f2f88cb31effa784a9aa555290e6b5c","identity_scope":"source_document_reference","source_type":"other","title":"Takeda Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TAK","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:21:13.968512+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.719,"status":"developing","publication_readiness":"review","dimensions":{"identity":1,"coverage":0.4,"freshness":1,"evidence_completeness":1,"source_authority":0.35,"cross_source_agreement":0.75,"temporal_completeness":0.222},"diagnostics":{"published_claims":16,"factual_claims":16,"claims_with_linked_evidence":16,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":9,"temporal_claims_with_valid_from":2,"missing_coverage_sections":["board_and_committees","governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","board_seat","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-11-16T04:49:37.426467+00:00","observed_at":"2026-11-16T04:49:37.426467+00:00","reviewed_at":"2026-11-16T04:49:37.426467+00:00","verified_at":"2026-11-16T04:49:37.426467+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":16,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/takeda-pharmaceutical-co-ltd/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}